UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 158

Sortiert nach

Posttranslational modifications of RUNX1 as potential anticancer targets

Oncogene, 2015-07, Vol.34 (27), p.3483-3492

2015

Volltextzugriff (PDF)

Protease-activated receptor-1 inhibits proliferation but enhances leukemia stem cell activity in acute myeloid leukemia

Oncogene, 2017-05, Vol.36 (18), p.2589-2598

2017

Volltextzugriff (PDF)

MITOTIC PERTURBATION IS A KEY MECHANISM OF ACTION OF DECITABINE IN MYELOID TUMOR TREATMENT

Leukemia research reports, 2024, Vol.21, p.100446, Article 100446

2024

Volltextzugriff (PDF)

UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO

Leukemia, 2016-03, Vol.30 (3), p.728-739

2016

Volltextzugriff (PDF)

High expression of ABCG2 induced by EZH2 disruption has pivotal roles in MDS pathogenesis

Leukemia, 2018-02, Vol.32 (2), p.419-428

2018

Volltextzugriff (PDF)

Pbx1 is a downstream target of Evi-1 in hematopoietic stem progenitors and leukemic cells

Oncogene, 2009-12, Vol.28 (49), p.4364-4374

2009

Volltextzugriff (PDF)

Evil defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemia

Oncogene, 2014-10, Vol.33 (42), p.5028

2014

Volltextzugriff (PDF)

The subtype-specific features of EVI1 and PRDM16 in acute myeloid leukemia

Haematologica (Roma), 2015-03, Vol.100 (3), p.e116

2015

Volltextzugriff (PDF)

Evi1 defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemia

Oncogene, 2014-10, Vol.33 (42), p.5028-5038

2014

Volltextzugriff (PDF)

EVI-1 interacts with histone methyltransferases SUV39H1 and G9a for transcriptional repression and bone marrow immortalization

Leukemia, 2010-01, Vol.24 (1), p.81-88

2010

Volltextzugriff (PDF)

Post-transplant endothelial disorder after hematopoietic SCT: a blinded autopsy study

Bone marrow transplantation (Basingstoke), 2012-09, Vol.47 (9), p.1243-1245

2012

Volltextzugriff (PDF)

AML1-Evi-1 specifically transforms hematopoietic stem cells through fusion of the entire Evi-1 sequence to AML1

Leukemia, 2008-06, Vol.22 (6), p.1241-1249

2008

Volltextzugriff (PDF)

Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells

Cell stem cell, 2008-08, Vol.3 (2), p.207-220

2008

Volltextzugriff (PDF)

Male predominance among Japanese adult patients with late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2003-12, Vol.32 (12), p.1175-1179

2003

Volltextzugriff (PDF)

Reverse Seroconversion of Hepatitis B Virus after Hematopoietic Stem Cell Transplantation

Leukemia & lymphoma, 2002-01, Vol.43 (11), p.2159-2163

2002

Volltextzugriff (PDF)

Functional Domains of Runx1 Are Differentially Required for CD4 Repression, TCRβ Expression, and CD4/8 Double-Negative to CD4/8 Double-Positive Transition in Thymocyte Development

The Journal of immunology (1950), 2005-03, Vol.174 (6), p.3526-3533

2005

Volltextzugriff (PDF)

A prospective trial to evaluate the safety and efficacy of pravastatin for the treatment of refractory chronic graft-versus-host disease

Transplantation, 2005-02, Vol.79 (3), p.372

2005

Volltextzugriff (PDF)

Rapid diagnosis of invasive pulmonary aspergillosis by quantitative polymerase chain reaction using bronchial lavage fluid

American journal of hematology, 2003-01, Vol.72 (1), p.27-30

2003

Volltextzugriff (PDF)

Clinical Significance of Peripheral Blood Erythroblastosis after Hematopoietic Stem Cell Transplantation

Leukemia & lymphoma, 2004-12, Vol.45 (12), p.2439-2443

2004

Volltextzugriff (PDF)

Reduced‐intensity bone marrow transplantation from an alternative unrelated donor for myelodysplastic syndrome of first‐donor origin

American journal of hematology, 2003-03, Vol.72 (3), p.220-222

2003

Volltextzugriff (PDF)

The role of ASXL1 in hematopoiesis and myeloid malignancies

Cellular and molecular life sciences : CMLS, 2019-07, Vol.76 (13), p.2511-2523

2019

Volltextzugriff (PDF)

Epigenetics in normal and malignant hematopoiesis: An overview and update 2017

Cancer science, 2017-04, Vol.108 (4), p.553-562

2017

Volltextzugriff (PDF)

Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformation

The Journal of experimental medicine, 2018-06, Vol.215 (6), p.1729-1747

2018

Volltextzugriff (PDF)

Xenograft models for normal and malignant stem cells

Blood, 2015-04, Vol.125 (17), p.2630-2640

2015

Volltextzugriff (PDF)

Mutant ASXL1 induces age-related expansion of phenotypic hematopoietic stem cells through activation of Akt/mTOR pathway

Nature communications, 2021-03, Vol.12 (1), p.1826-20, Article 1826

2021

Volltextzugriff (PDF)

1 – 25 von 158

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(151)
Mit Volltextzugriff
(147)

Publikationsform

Artikel
(157)
Berichte
(1)

Sprache

Englisch
(153)
Japanisch
(56)

Erscheinungsjahr

n.n

Thema

Science & Technology
(90)
Life Sciences & Biomedicine
(77)
Humans
(60)
Animals
(58)
Mice
(45)
Hematology
(35)
Oncology
(26)
Biological And Medical Sciences
(21)
Mutation
(20)
Cell Biology
(19)
Leukemia
(19)
Medical Sciences
(19)
Acute Myeloid Leukemia
(16)
Biochemistry & Molecular Biology
(15)
Female
(15)
Hematopoiesis
(15)
Hematopoietic Stem Cells - Metabolism
(15)
Leukemia, Myeloid, Acute - Genetics
(14)
Mice, Inbred C57bl
(14)
Dna-Binding Proteins - Genetics
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(42)
Experimental Hematology
(12)
Cancer Science
(6)
Cell Reports
(6)
Leukemia
(6)
International Journal Of Hematology
(5)
Nature Communications
(5)
Oncogene
(5)
Biochemical And Biophysical Research Communications
(4)
Rinsho Ketsueki
(4)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Posttranslational modifications of RUNX1 as potential anticancer targets

Protease-activated receptor-1 inhibits proliferation but enhances leukemia stem cell activity in acute myeloid leukemia

MITOTIC PERTURBATION IS A KEY MECHANISM OF ACTION OF DECITABINE IN MYELOID TUMOR TREATMENT

UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO

High expression of ABCG2 induced by EZH2 disruption has pivotal roles in MDS pathogenesis

Pbx1 is a downstream target of Evi-1 in hematopoietic stem progenitors and leukemic cells

Evil defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemia

The subtype-specific features of EVI1 and PRDM16 in acute myeloid leukemia

Evi1 defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemia

EVI-1 interacts with histone methyltransferases SUV39H1 and G9a for transcriptional repression and bone marrow immortalization

Post-transplant endothelial disorder after hematopoietic SCT: a blinded autopsy study

AML1-Evi-1 specifically transforms hematopoietic stem cells through fusion of the entire Evi-1 sequence to AML1

Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells

Male predominance among Japanese adult patients with late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation

Reverse Seroconversion of Hepatitis B Virus after Hematopoietic Stem Cell Transplantation

Functional Domains of Runx1 Are Differentially Required for CD4 Repression, TCRβ Expression, and CD4/8 Double-Negative to CD4/8 Double-Positive Transition in Thymocyte Development

A prospective trial to evaluate the safety and efficacy of pravastatin for the treatment of refractory chronic graft-versus-host disease

Rapid diagnosis of invasive pulmonary aspergillosis by quantitative polymerase chain reaction using bronchial lavage fluid

Clinical Significance of Peripheral Blood Erythroblastosis after Hematopoietic Stem Cell Transplantation

Reduced‐intensity bone marrow transplantation from an alternative unrelated donor for myelodysplastic syndrome of first‐donor origin

The role of ASXL1 in hematopoiesis and myeloid malignancies

Epigenetics in normal and malignant hematopoiesis: An overview and update 2017

Expression of mutant Asxl1 perturbs hematopoiesis and promotes susceptibility to leukemic transformation

Xenograft models for normal and malignant stem cells

Mutant ASXL1 induces age-related expansion of phenotypic hematopoietic stem cells through activation of Akt/mTOR pathway

Suchergebnisse filtern